Najmutdinova D.K

5 ta ish

Toshkent davlat tibbiyot universiteti

1. DIABETES MELLITUS AND COVID-19. CARDIOVASCULAR COMPLICATIONS AND COURSE OF TYPE 2 DIABETES MELLITUS AFTER CORONAVIRUS INFECTION

   Najmutdinova D.K, Urunbayeva D.A, N.G. Shinde +1

   MaqolaOAOchiq kirishCOVID-19 Clinical Research StudiesJournal of Medical Genetics and Clinical Biology20240 iqtibos

   ABIABI:AkademIndex/2024.article.009370

2. DIABETIC KETOACIDOSIS ASSOCIATED WITH EMPAGLIFLOZIN THERAPY : MECHANISMS, RISC FACTORS AND CLINICAL IMPLICATIONS

   Najmutdinova D.K, Kurbanova A.B.

   BoshqaZenodo (CERN European Organization for Nuclear Research)20260 iqtibos

   ABIABI:AkademIndex/2026.other.876704

3. DIABETIC KETOACIDOSIS ASSOCIATED WITH EMPAGLIFLOZIN THERAPY : MECHANISMS, RISC FACTORS AND CLINICAL IMPLICATIONS

   Najmutdinova D.K, Kurbanova A.B.

   BoshqaOAOchiq kirishZenodo (CERN European Organization for Nuclear Research)20260 iqtibos

   ABIABI:AkademIndex/2026.other.876832

4. BEYOND BODY MASS INDEX: UNCOVERING "HIDDEN" CARDIOMETABOLIC RISK IN NORMAL-WEIGHT TYPE 2 DIABETES PATIENTS USING WHTR AND AIP TRAJECTORIES

   Najmutdinova D.K, Abdumutalibova I.T., Worldly Knowledge Publishing Centretashkilot

   BoshqaZenodo (CERN European Organization for Nuclear Research)20260 iqtibos

   ABIABI:AkademIndex/2026.other.900118

5. BEYOND BODY MASS INDEX: UNCOVERING "HIDDEN" CARDIOMETABOLIC RISK IN NORMAL-WEIGHT TYPE 2 DIABETES PATIENTS USING WHTR AND AIP TRAJECTORIES

   Najmutdinova D.K, Abdumutalibova I.T., Worldly Knowledge Publishing Centretashkilot

   BoshqaOAOchiq kirishZenodo (CERN European Organization for Nuclear Research)20260 iqtibos

   ABIABI:AkademIndex/2026.other.900697